enzo.com (ENZ): Long-Term Debt to Capital Ratio

Enzo Biochem, Inc. (ENZ) relies on a staff of precision biologists and standards experts, fostering an academic environment with a high-quality benefits package. Business revenues are generated by the supply of diagnostic systems and reagents to clinics, where the indicator stands at 0.05. The company's price evolution on the GURU.Markets platform reflects the long-term debt dynamics relative to the equity of this laboratory solutions provider.

This indicator determines the degree of dependence of the financing structure on long-term debt. By analyzing the long-term debt load relative to equity, the investor assesses the balance between own assets and credit obligations. The ratio is calculated by dividing the total amount of long-term loans by the amount of shareholders' equity. For Enzo Biochem, Inc. (ENZ), this metric is critical, as the company's financial stability directly correlates with the efficiency of implementing new diagnostic tests. High debt dependence may amplify risks in the event of reduced insurance payouts or patent disputes.